ArticleExperimental hematology & oncology2019

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma.

Ravi Potluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.